Elloe AI launched AI-powered public health pilots in Africa, aiming to cut misdiagnoses by 62% and establish global models for safe, compliant healthcare AI.

Elloe AI initiated a collaboration with Johns Hopkins to advance real-time medical AI auditing and compliance frameworks. This partnership strengthens clinical validation of Elloe’s AI safety tools, focusing on reducing diagnostic errors and bias in large-scale hospital deployments.

Elloe AI surpassed $10M in enterprise contract pipeline, reflecting surging demand for AI trust and safety solutions across healthcare, finance, and government sectors globally.

Elloe AI was selected by the EU Commission to lead a pilot program auditing public LLMs in healthcare, reinforcing Elloe’s leadership in AI compliance and advancing public-sector safety protocols across Europe.

Elloe AI strengthened its leadership with the addition of Jaan Tallinn, co-founder of DeepMind, and Joshua Achiam, Head of AI Safety at OpenAI, as strategic advisors. Their unparalleled expertise in AI risk, governance, and global safety standards amplifies Elloe’s mission to deliver the world’s most trusted AI compliance platform.

Elloe AI partnered with NVIDIA to co-develop SAFEGPU™, integrating Elloe’s AI governance suite at the GPU level—enabling faster, hardware-embedded compliance and safety for AI enterprises worldwide.

Elloe AI scaled its team to 15 full-time employees, expanding engineering, compliance, and customer success capabilities to meet growing enterprise needs.

Elloe AI was honored at the World Economic Forum as a Responsible AI Pioneer, recognized for its global leadership in AI safety and its impact preventing 100K+ medical errors and $20M in biased loan approvals.

Elloe AI opened its European office in Estonia, expanding its EU footprint to strengthen compliance services and enterprise support across Europe.

Elloe AI reached $2.4M ARR with 1900% year-over-year growth, maintaining 97% client retention and an 80% POC-to-contract conversion rate, reinforcing market dominance in AI governance.

Elloe AI formalized a partnership with Rice University to co-develop global academic standards for medical AI safety, supporting best practices for clinical AI and healthcare regulators worldwide.

As AI’s immune system, Elloe AI’s TruthChecker™ 2.0 was adopted by Germany to power its national AI audit framework, setting the gold standard for real-time fact-checking, bias detection, and compliance in Europe.

Elloe AI launched Autopsy™, its cutting-edge bias auditing and compliance enforcement tool, enabling enterprises to continuously monitor and diagnose AI systems for fairness and policy adherence.

Elloe AI relocated its global headquarters to Austin, Texas, positioning itself at the heart of the U.S. AI and tech innovation ecosystem to fuel talent acquisition, enterprise growth, and deeper collaboration with key partners.

Elloe AI surpassed $1M in ARR with 95% client retention, marking a significant revenue milestone as enterprise demand surged for AI trust and safety solutions.

Elloe AI launched TruthChecker™ 2.0, achieving a 95% reduction in AI hallucinations and bias, now actively deployed across healthcare and finance sectors for mission-critical compliance.